期刊投稿持久战:练功还是得从娃娃抓起

2016-02-29 MedSci MedSci原创

MedSci医学“选刊一指禅,你敢抢我就敢送”活动,火热进行中……想SCI投稿要点么?想了解更多选刊方面的经验请扫描下方二维码下载MedSci医学App,参与活动即可。这次活动更有高峰日迪斯尼门票相送!更有价值2000元专家选刊相送!更有十万积分送!众所周知,期刊投稿不是一朝一夕能够解决的,从开始投稿的那天起,就注定了这将是一场旷日持久的战争,既要做好战前准备,在漫长投稿过程中,也要做足准备。

MedSci医学“选刊一指禅,你敢抢我就敢送”活动,火热进行中……

想SCI投稿要点么?想了解更多选刊方面的经验

请扫描下方二维码下载MedSci医学App,参与活动即可。

这次活动

更有高峰日迪斯尼门票相送!

更有价值2000元专家选刊相送!

更有十万积分送!



众所周知,期刊投稿不是一朝一夕能够解决的,从开始投稿的那天起,就注定了这将是一场旷日持久的战争,既要做好战前准备,在漫长投稿过程中,也要做足准备。

没有投稿经验的小白,怎么把文章投好呢?那就要从源头抓起,夯实基础,一起苦练期刊投稿“娃娃功”。



下面就为大家分享一下,在投稿的过程中,有哪些基本功,是我们需要知道的?

一、首先一定要注意杂志的发表范围

超出范围的千万别投,要不就是浪费时间;另外,每个杂志都有他们的具体格式要求,一定要按照他们的要求把论文写好,免得浪费时间。

二、论文写作一定要言简意赅

特别是摘要和结论不能重复,发现有很多论文这两部分没有差别。个人认为,摘要是引人入胜的"药引子",要留悬念;而结论是你论文得出的有证据的东西,要简单明了。尽量避免数据的简单堆积。论文的重点应该在观点上,保证一篇论文一个新观点,已经足够了。

三、评阅人的选择

投稿时,一定要找和你做研究内容相近领域的专家作评阅人,最好是国外的,不是说国内的不好,但就怕有人和你(或你老板)有过节,而且国内的很多所谓专家水平一般,且小心眼。

四、cover letter

要简单介绍你的工作的创新性,这样便于论文的快速发表,当然也应该客气几句,让编辑感到心里舒服,主要是夸杂志好之类的话;有人写coverletter,就是写上题目、然后说很荣幸投稿之类地话,也有人干脆把摘要全写上,这样个人认为不好,一定用两到三句话说明你论文“新”在哪,这个非常重要。

五、催稿信的问题

前些时候,看到论坛上很多人说不能写信催编辑,个人认为没关系,必要催信能够让人重视你的论文,一定要让人感到,你的论文在这发不了,好多地方在等着发呢(但很多牛杂志,可不吃这套哟,人家不缺稿,嘿嘿)。当然写信的时候要客气,说一些快速发表对于学术讨论和促进工作等方面的重要性之类的话。

六、能写英文,就不投中文稿

特别是不投中文杂志英文版,好不容易憋了篇英文,还投到低水平的杂志,很不甘心;最重要的是国内杂志要钱,而国外很多不要。自从国内某杂志告诉我他们之所以收我很高的版面费是为了他们的生存时,我发誓包括以后我的学生就不再投中文杂志了

七、英语不好没关系

是人都知道我们英语没英国和美国人地道,但只要能表达清楚你要表达的意思就好了。而且等审稿人提出来时,一定要从头到尾改一遍。你会发现,这样多次发论文后,你的英语写作水平在一天天提高。拿两年前的论文过来,自己都感觉写得很烂,哈哈~

八、坚持就是胜利

按照审稿人的建议好好改你的论文,只要坚持投稿,就一定能够被接收的,如果论文被某杂志拒稿,但不提倡降低杂志质量再投(应该根据审稿人意见修改后找合适的杂志);有人认为低影响因子的杂志一定中的几率高,我也这么认为,但一般低影响因子的杂志论文出稿比较慢!

最后,小编再教大家一招

相信很多作者都遇到过这种情况,向SCI期刊投稿很长时间,没有收到期刊审稿意见(一般在两月以上,两月以内很正常,具体可见SCI审稿流程:http://news.bioon.com/article/6678749.html),但因晋升职称、毕业等原因急于发表时,该怎么办呢?写信催?我们往往担心是否太冒失了,但时间紧急又不得不催时,该用怎样的语言去催期刊呢?

催稿信

我个人觉得:以正当的理由,委婉地向主编催稿,对于加快审稿速度,还是可行的。尽量客气一点,避免被无良杂志退稿。

Dear Prof. Dr. Editor ***

I submitted our latest work to your journal *** last November. I want to know the review process. If there are some reponses from the reviewers. Would you please tell me the results so that I can deal with it as early as possible? Please understand me that fast publication of our work is important for me.

I appreciate your contribution to the publication of the high quality papers.

Kind thanks to you for your care.

Best Regards

Yours sincerely

撤稿信

投稿后审稿人提出修改,需要补充数据、理论等一堆内容,短时间不能修定,只好撤稿,撤稿也需要理由。

Dear Editor,

Thank you very much for your kind remind and helps. However, we are sorry that we have to withdraw the submission of our paper (Manuscript Number,MN:…) . The reason is that, first, if we revise the paper according to the reviewers' comments point by point, we will pay much time to make tests and then plot the data in the revised paper, second, we feel that we have not yet studied our work completely and have some difficulties to answer some questions of the reviewers' comments and add their answers or solutions in the revised paper quickly. Of course, our work in this paper is complex and difficult because it is related with the magnetism, mechanics, electrostatics, electrics and some couplings among them. I am very sorry that we had to make this decision and continue our investigation of this work further. I appreciate the reviewers very much for their careful work and helpful suggestions. Thank you again.

Kind Regards,

Your name

Response

最后附上作者修改稿件时,给编辑和审稿人的response

Responses to the reviewers’ comments

Dear Editor,

Thank you very much for your reply and help. Thanks a lot for the reviewers’ comments and their kind suggestions of our manuscript entitled “Title of your paper”. We provide this cover letter to explain, point by point, the details of our revisions in the manuscript and our responses to the reviewers’ comments as follows. In order to make the changes easily viewable for you and the reviewers, in the revised paper, we marked the revision with red color. Besides, we have carefully checked through the whole manuscript and corrected some grammar mistakes. We hope the revised paper would satisfy you and the reviewers.

We are looking forward to hearing from you soon.

Kind Regards,

Your name

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1704017, encodeId=11f91e04017bc, content=<a href='/topic/show?id=cb9660e9663' target=_blank style='color:#2F92EE;'>#期刊投稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60796, encryptionId=cb9660e9663, topicName=期刊投稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=162930619596, createdName=yangcx0925, createdTime=Sun Nov 13 01:01:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66530, encodeId=86ee6653000, content=额…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:19:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66372, encodeId=38bb663e27f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Feb 29 23:35:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66325, encodeId=83c96632573, content=bu'bu, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Mon Feb 29 14:48:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1704017, encodeId=11f91e04017bc, content=<a href='/topic/show?id=cb9660e9663' target=_blank style='color:#2F92EE;'>#期刊投稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60796, encryptionId=cb9660e9663, topicName=期刊投稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=162930619596, createdName=yangcx0925, createdTime=Sun Nov 13 01:01:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66530, encodeId=86ee6653000, content=额…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:19:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66372, encodeId=38bb663e27f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Feb 29 23:35:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66325, encodeId=83c96632573, content=bu'bu, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Mon Feb 29 14:48:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-03-01 破风4392

    额…………

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1704017, encodeId=11f91e04017bc, content=<a href='/topic/show?id=cb9660e9663' target=_blank style='color:#2F92EE;'>#期刊投稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60796, encryptionId=cb9660e9663, topicName=期刊投稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=162930619596, createdName=yangcx0925, createdTime=Sun Nov 13 01:01:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66530, encodeId=86ee6653000, content=额…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:19:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66372, encodeId=38bb663e27f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Feb 29 23:35:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66325, encodeId=83c96632573, content=bu'bu, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Mon Feb 29 14:48:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-02-29 sanshengshi

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1704017, encodeId=11f91e04017bc, content=<a href='/topic/show?id=cb9660e9663' target=_blank style='color:#2F92EE;'>#期刊投稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60796, encryptionId=cb9660e9663, topicName=期刊投稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=162930619596, createdName=yangcx0925, createdTime=Sun Nov 13 01:01:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66530, encodeId=86ee6653000, content=额…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:19:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66372, encodeId=38bb663e27f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Feb 29 23:35:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66325, encodeId=83c96632573, content=bu'bu, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Mon Feb 29 14:48:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-02-29 黄庆

    bu'bu

    0

相关资讯

您还在纠结向哪个开放获取的期刊投稿吗?

Impact Factor: 3.523 Ranking: 2014: 73/211 (Oncology) 期刊主编: Yusuke Nakamura, The University of Chicago Cancer Science 给您五大投稿理由!